期刊文献+

动物模型在肺部真菌病研究中的应用 被引量:2

Application of Animal Models in Research of Pulmonary Mycosis
下载PDF
导出
摘要 真菌病成为日益严重的临床问题,深部真菌感染尤其是肺部真菌感染呈持续增多趋势。肺部真菌病往往发生于免疫低下或有基础疾病的患者,其具体发病机制尚不完全清楚。动物模型不仅为真菌病病因学研究提供有效的途径,还能在抗真菌药物、免疫调节剂及可能的疫苗的研究中提供多方面的帮助。动物实验中所观察到的病理改变可能对发病机理的探索有所帮助。实验动物研究有助于我们明晰各种参数的作用机理,比如抗原、暴露途径、基因背景即反应修饰在发病中的作用,进一步的,通过基因缺失或插入或结合,我们有可能了解某种特定的细胞、受体、介质在发病过程中的机理,其结果可能应用到人类疾病上。 Mycoses often happen under certain conditions. However, along with the recent increase of various inducing factors, deep and disseminated fungal infections have also increased day by day. The pathogenesis of pulmonary fungal diseases is not fully understood until now. Both common and distinct pathological features occurring in natural and experimental diseases are of great interest as they may serve to identify the key elements in the pathogenesis. Experimentally induced mycosis can be used as a model to understand various parameters such as antigen and route of exposure, genetic background and the role of response modifiers in the disease process. Furthermore, animals with targeted gene deletion or with insertion of transgenes can be studied and the roles of specific cells, receptors and mediators in the pathogenesis can be more precisely defined. The resulting conclusions can be used to formulate new hypothesis and explore their application in the treatment for human diseases.
出处 《中国实验动物学报》 CAS CSCD 2008年第4期305-308,共4页 Acta Laboratorium Animalis Scientia Sinica
基金 军队十一五资助课题(免疫低下时真菌性肺炎的实验动物研究06MB225)
关键词 肺感染 真菌病 模型 动物 Lung infection Mycoses Animal model
  • 相关文献

参考文献29

  • 1刘正印,王爱霞.系统性真菌感染的现状[J].中国临床医生杂志,2005,33(11):26-27. 被引量:1
  • 2陈刚,颜春松.肺部真菌感染的诊治进展[J].国际呼吸杂志,2007,27(10):790-793. 被引量:6
  • 3陈丕仁,崔立,侯加法.慢性阻塞性肺病动物模型的研究进展[J].中国实验动物学报,2007,15(3):238-242. 被引量:18
  • 4焦光宇,聂志伟,刘春利,李承峰,刘冬娟,何平.小剂量脂多糖气管内滴注制备急性肺损伤动物模型的探究[J].中国实验动物学报,2007,15(4):292-295. 被引量:28
  • 5Habicht JM, Preiss M, Passweg J, et al. Invasive pulmonary aspergillosis: effects of early resection in a neutropenic rat model[ J]. Eur J Cardiothorac Surg, 2002, 22(5):728- 732.
  • 6Lewis RE, Wiederhold NP. Murine model of invasive aspergillosis [ J]. Methods Mol Med, 2005,118 : 129 - 142.
  • 7Chandrasekar PH, Cutright JL, Manavathu EK. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis[J]. Clin Microbiol Infect, 2004, 10(10) : 925 - 928.
  • 8Sheppard DC, Rieg G, Chiang LY, et al. Novel inhalational routine model of invasive pulmonary aspergillosis [ J ]. Antimicrob Agents Chemother, 2004, 48(5):1908- 1911.
  • 9Steinbach WJ, Benjamin DK Jr, Trasi-SA, et al. Value of an inhalational model of invasive aspergillosis [ J ]. Med Mycol, 2004, 42(5) :417 - 425.
  • 10Wormley FL Jr; Cox GM, Perfect JR. Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans calcineurin A mutant strain[J]. Microbiol Pathog, 2005, 38(2- 3) :113 - 123.

二级参考文献73

  • 1黄晓军.血液病/恶性肿瘤患者侵袭性真菌感染的诊断标准与治疗原则(草案)[J].中华内科杂志,2005,44(7):554-556. 被引量:423
  • 2Wakabayashi H,Takakura N,Teraguchi S,et al.Lactoferrin feeding augments peritoneal macrophage activities in mice intraperitoneally injected with inactivated Candida albicans.Microbiol Immunol,2003,47:37-43.
  • 3Farah CS,Gotjamanos T,Seymour GJ,et al.Cytokines in the oral mucosa of mice infected with Candida albicans.Oral Microbiol Immunol,2002,17:375-378.
  • 4Magari SR,Rivera VM,Iuliucci JD,et al.Pharmacologic control of a humanized gene therapy system implanted into nude mice.J Clin Invest,1997,100:2865-2872.
  • 5Romani L,Mencacci A,Cenci E,et al.Natural killer cells do not play a dominant role in CD4+ subset differentiation in Candidaalbicans-infected mice.Infect Immun,1993,61:3769-3774.
  • 6Farah CS,Gotjamanos T,Seymour GJ,et al.Cytokines in the oral mucosa of mice infected with Candida albicans.Oral Microbiol and Immunol,2002,17:375-378.
  • 7Black CA,Eyers FM,Russell A,et al.Increased severity of Candida vaginitis in BALB/c nu/nu mice versus the parent strain is not abrogated by adoptive transfer of T cell enriched lymphocytes.J Reprod Immunol,1999,45:1-18.
  • 8Lyman CA, Gonzalez C, Schneider M, et al. Effects of the hematoregulatory peptide SK&F 107647 alone and in combination with amphotericin B against disseminated candidiasis in persistently neutropenic rabbits. Antimicrob Agents and Chemother, 1999, 43(9),2165~2169.
  • 9Groll AH, Gonzalez CE, Girin N, et al. Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits :efficacy,safety and non-compartmental pharmacokinetics.Antimicrob Chemother, 1999,43 (1) : 95~103.
  • 10Ellis M. Invasive fungal infections: evolving challenges for diagnosis and therapeutics[J]. Mol Immunol, 2001,38:947 -957.

共引文献57

同被引文献17

  • 1杨琼,宋祥福,王桂云.系统性白色念珠菌感染小鼠动物模型的研究[J].东北师大学报(自然科学版),2005,37(2):86-89. 被引量:14
  • 2朱正鹏,贾国凤,沈勤,杨微荣,马健波.播散性隐球菌病尸检1例并文献复习[J].临床与实验病理学杂志,2006,22(2):248-249. 被引量:4
  • 3尹瑞瑞,朱敬先.系统性真菌感染动物模型的应用进展[J].中国真菌学杂志,2006,1(3):182-185. 被引量:2
  • 4颜召文,吴平平,蔡军,姚季生.急性肺隐球菌病合并肺出血尸检一例报道[J].上海交通大学学报(医学版),2007,27(8):1039-1040. 被引量:5
  • 5Jarvis J N, Harrison T S. Pulmonary cryptococcosis[J]. Semin Re-spir Crit Care Med,2008,29(2) :141-150.
  • 6Chang W C, Tzao C, Hsu H H, et al. Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immuno- competent and immunocompromised patients[J]. Chest, 2006,129 (2) :333-340.
  • 7Woo J H, Ciporkin G, Lee C, et al. Pulmonary cryptococcosis[J]. Semin Roentgenol, 1996,31 (1) : 67- 75.
  • 8Kyoung D S,Kyung S L, Man P C, et al. Pulmonary cryptococco- sis: imaging findings in 23 non-AIDS patients[J]. Korean J Radi- ol, 2010,11(4) :407 -416.
  • 9Steven E Z, Ann N L, Michael F,et al. Pulmonary cryptococco sis: CT and pathologic findings[J]. J Comput Assist Tomogr, 2006,26(3):330-334.
  • 10Aberg J A, Mundy L M, Powderly W G. Pulmonary cryptoeoc- eosis in patients without HIV infeetion[J]. Chest, 1999,11(5) : 734-74O.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部